Literature DB >> 25827407

Percutaneous penetration of silver from a silver containing garment in healthy volunteers and patients with atopic dermatitis.

Olivier A Pluut1, Carlotta Bianco2, Ivone Jakasa3, Maaike J Visser1, Petra Krystek4, Francesca Larese-Filon5, Thomas Rustemeyer6, Sanja Kezic7.   

Abstract

Human data on dermal absorption of silver under "in use" scenario are scarce which hampers health risk assessment. The main objective of the present study was to determine percutaneous penetration of silver after dermal exposure to silver containing garment in healthy individuals and atopic dermatitis (AD) patients. Next to assess pro-inflammatory effect of silver in the skin. Healthy subjects (n=15) and patients with AD (n=15) wore a sleeve containing 3.6% (w/w) silver on their lower arms for 8h during 5 consecutive days. The percutaneous penetration parameters were deduced from the silver concentration-depth profiles in the stratum corneum (SC) collected by adhesive tapes. Furthermore, silver was measured in urine samples collected before and after exposure. Inflammatory response was assessed by measuring IL-1α and IL-1RA in the exposed and non-exposed skin sites. Dermal flux of silver in healthy subjects and AD patients was respectively 0.23 and 0.20 ng/cm(2)/h. The urine silver concentrations showed no increase after exposure. Furthermore, exposure to silver did not lead to the changes in the profiles of IL-1α and IL-1RA. Dermal absorption of silver under "real life scenario" was lower than the current reference dose. Furthermore, dermal exposure did not lead to altered expression of inflammatory IL-1 cytokines in the skin.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Atopic dermatitis; Cytokines; Dermal exposure; Percutaneous penetration; Silver

Mesh:

Substances:

Year:  2015        PMID: 25827407     DOI: 10.1016/j.toxlet.2015.03.014

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

Review 1.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

2.  Characterization of silver particles in the stratum corneum of healthy subjects and atopic dermatitis patients dermally exposed to a silver-containing garment.

Authors:  Carlotta Bianco; Maaike J Visser; Olivier A Pluut; Vesna Svetličić; Galja Pletikapić; Ivone Jakasa; Christoph Riethmuller; Gianpiero Adami; Francesca Larese Filon; Diane Schwegler-Berry; Aleksandr B Stefaniak; Sanja Kezic
Journal:  Nanotoxicology       Date:  2016-10-05       Impact factor: 5.913

Review 3.  Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP).

Authors:  Elena Galli; Anna Belloni Fortina; Giampaolo Ricci; Nunzia Maiello; Iria Neri; Ermanno Baldo; Irene Berti; Domenico Bonamonte; Lucetta Capra; Elena Carboni; Rossella Carello; Francesca Caroppo; Giovanni Cavagni; Iolanda Chinellato; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Vito Di Lernia; Marzia Duse; Cesare Filippeschi; Arianna Giannetti; Mattia Giovannini; Amelia Licari; Gian Luigi Marseglia; Manuela Pace; Annalisa Patrizi; Giovanni Battista Pajno; Diego Peroni; Alberto Villani; Lawrence Eichenfield
Journal:  Ital J Pediatr       Date:  2022-06-14       Impact factor: 3.288

4.  The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial): study protocol for a pragmatic randomized controlled trial.

Authors:  Karin B Fieten; Ron A Tupker; Aviël Ragamin; Jill de Wit; Minke M F van Mierlo; Marieke S Jansen; Madelon B Bronner; Renske Schappin; Frank H J Schuren; Margreet L E Romeijn; Bernd W M Arents; Suzanne Polinder; Marlies de Graaf; Thomas Rustemeyer; Marie L A Schuttelaar; Suzanne G M A Pasmans
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.